241 related articles for article (PubMed ID: 32737661)
1. Activation of cell-penetrating peptide fragments by disulfide formation.
Tooyserkani R; Lipiński W; Willemsen B; Löwik DWPM
Amino Acids; 2020 Aug; 52(8):1161-1168. PubMed ID: 32737661
[TBL] [Abstract][Full Text] [Related]
2. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate.
Lin CW; Kuo JH; Jan MS
J Drug Target; 2012 Jul; 20(6):515-23. PubMed ID: 22632162
[TBL] [Abstract][Full Text] [Related]
3. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos.
Gentry SB; Nowak SJ; Ni X; Hill SA; Wade LR; Clark WR; Keelaghan AP; Morris DP; McMurry JL
PLoS One; 2021; 16(9):e0254468. PubMed ID: 34473728
[TBL] [Abstract][Full Text] [Related]
4. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
Kardani K; Bolhassani A
PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
Meloni BP; Craig AJ; Milech N; Hopkins RM; Watt PM; Knuckey NW
Cell Mol Neurobiol; 2014 Mar; 34(2):173-81. PubMed ID: 24213248
[TBL] [Abstract][Full Text] [Related]
6. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
Brooks N; Esparon S; Pouniotis D; Pietersz GA
Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models.
Tréhin R; Krauss U; Beck-Sickinger AG; Merkle HP; Nielsen HM
Pharm Res; 2004 Jul; 21(7):1248-56. PubMed ID: 15290867
[TBL] [Abstract][Full Text] [Related]
8. Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.
Rullo A; Qian J; Nitz M
Biopolymers; 2011 Oct; 95(10):722-31. PubMed ID: 21538329
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
10. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization.
Futaki S; Nakase I
Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
Turner JJ; Arzumanov AA; Gait MJ
Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
[TBL] [Abstract][Full Text] [Related]
13. Thermodynamics of cell-penetrating HIV1 TAT peptide insertion into PC/PS/CHOL model bilayers through transmembrane pores: the roles of cholesterol and anionic lipids.
Hu Y; Patel S
Soft Matter; 2016 Aug; 12(32):6716-27. PubMed ID: 27435187
[TBL] [Abstract][Full Text] [Related]
14. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
15. Biological effects of Tat cell-penetrating peptide: a multifunctional Trojan horse?
Lee D; Pacheco S; Liu M
Nanomedicine (Lond); 2014 Jan; 9(1):5-7. PubMed ID: 24354809
[No Abstract] [Full Text] [Related]
16. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide.
Meerovich I; Muthukrishnan N; Johnson GA; Erazo-Oliveras A; Pellois JP
Biochim Biophys Acta; 2014 Jan; 1840(1):507-15. PubMed ID: 24135456
[TBL] [Abstract][Full Text] [Related]
17. New generation CPPs show distinct selectivity for cancer and noncancer cells.
Tansi FL; Filatova MP; Koroev DO; Volpina OM; Lange S; Schumann C; Teichgräber UK; Reissmann S; Hilger I
J Cell Biochem; 2019 Apr; 120(4):6528-6541. PubMed ID: 30362167
[TBL] [Abstract][Full Text] [Related]
18. Membrane-bound dynamic structure of an arginine-rich cell-penetrating peptide, the protein transduction domain of HIV TAT, from solid-state NMR.
Su Y; Waring AJ; Ruchala P; Hong M
Biochemistry; 2010 Jul; 49(29):6009-20. PubMed ID: 20550193
[TBL] [Abstract][Full Text] [Related]
19. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
[TBL] [Abstract][Full Text] [Related]
20. Enhanced cellular uptake of near-infrared triggered targeted nanoparticles by cell-penetrating peptide TAT for combined chemo/photothermal/photodynamic therapy.
Wu H; You C; Chen F; Jiao J; Gao Z; An P; Sun B; Chen R
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109738. PubMed ID: 31349475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
